ArticleCritical care (London, England)2026
The economic value of preventing projected sepsis-related deaths among adults in 79 countries, 2000-2023, with projections to 2050: a modelling study.
Article in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSepsis remains a major global health burden, yet the economic value of reducing avoidable sepsis-related mortality is not well established. This study aimed to evaluate global trends in adult sepsis-related mortality and estimate the economic values of reducing avoidable deaths from sepsis between 2000 and 2023, with projections to 2050.
methodsSepsis-related mortality data for adults aged ≥ 20 years were obtained from 79 countries included in the World Health Organization (WHO) Mortality Database for the period 2000–2023. Bayesian neural network age–period–cohort projections of mortality through 2050, with locally weighted scatterplot smoothing incorporated to stabilize temporal continuity. Avoidable mortality was defined as mortality rates exceeding the 20th percentile derived from a frontier model. The economic value of reducing avoidable mortality to frontier levels was estimated using the value of a statistical life, expressed as a proportion of annual income in 2021 international dollars (Int$). All analyses were stratified by age, sex, and five World Bank–based region, and results are presented with 95% confidence intervals (CIs).
resultsGlobal age-standardized mortality rate from sepsis increased from 9.15 deaths per 100,000 population in 2000 to 12.77 (95% CI, 8.67–17.72) in 2023 and is projected to reach 20.32 (14.61–27.55) in 2050. In 2023, approximately 61.34% of all sepsis-related mortality were considered avoidable, with adults aged ≥ 70 years contributing disproportionately to mortality and, consequently, to the overall economic estimates, reflecting the distribution of mortality rather than any differential valuation of life by age. The global economic value of reducing avoidable deaths was estimated at Int$ 62.6 billion in 2023 (1.41% of annual income). Males had a slightly higher proportion of annual income represented by the estimated economic value (1.48%) than females (1.35%), reflecting differences in income levels and mortality patterns rather than sex-specific preferences. Regional disparities were substantial, highest in North America (1.80%) and lowest in Europe and Central Asia (1.00%).
conclusionsAlthough sepsis-related mortality has increased, most deaths remain avoidable, suggesting substantial scope for improvement. Further reductions in mortality could yield considerable and growing economic benefits, particularly through interventions targeting older adults and high-burden regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.